A human serotonin transporter mutation causes constitutive activation of transport activity

被引:118
作者
Kilic, F
Murphy, DL
Rudnick, G [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA
[2] NIMH, Clin Sci Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1124/mol.64.2.440
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A rarely occurring variant of human serotonin transporter (hSERT) was tested for its functional consequences in HeLa and COS-7 cells. The variant, in which Ile-425 is converted to Val, was significantly different from wild type with respect to its catalytic properties. In both cell types, rates of serotonin (5-HT) transport were higher for the I425V variant. Both an increase in V-max and a decrease in K-M caused this increase in rate. The increase in V-max was not accounted for by increases in transporter expression or in the distribution of transporter between the cell surface and intracellular pools. The decrease in K-M was accompanied by a decrease in the K-D for binding of the cocaine analog 2beta-carbomethoxy-3beta- (4-[I-125] iodophenyl) tropane. In both HeLa and COS-7 cells, the nitric oxide donor S-nitroso-N-acetylpenicillamine increased the activity of wild-type hSERT to that of the variant but did not change the activity of the I425V variant. This stimulation was prevented by the presence of oxyhemoglobin, which quenches nitric oxide, and by an inhibitor of guanylyl cyclase.
引用
收藏
页码:440 / 446
页数:7
相关论文
共 33 条